Sensei Biotherapeutics (SNSE) Reiterated at Overweight by Cantor Fitzgerald

June 4, 2026 7:00 AM

Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Sensei Biotherapeutics (NASDAQ: SNSE).The analyst commented, "Following our initiation of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found